TNF and rheumatoid arthritis: Prophylactic administration of a TNF-α inhibitor ameliorated glycocalyx degradation in response to low-dose endotoxin in healthy volunteers (12), and a combination therapy of methotrexate and/or a TNF-α inhibitor in rheumatoid arthritis patients decreased syndecan-1 for greater than 6 weeks (122).